News & events.

Our news.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News

September 16, 2021

Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19

News

September 15, 2021

AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines

News

September 13, 2021

AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

News

September 10, 2021

AbCellera to Present Virtually at the BofA Securities & Tech Solutions for Drug Discovery Conference

Event

August 21, 2021

Antibody Engineering & Therapeutics US 2021

Event

August 21, 2021

PEGS Europe 2021

Event

August 21, 2021

Discovery on Target 2021

Event

August 21, 2021

Festival of Biologics EU 2021

News

August 12, 2021

AbCellera Reports Q2 2021 Business Results

News

August 4, 2021

EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative Medicines